According to the literature, ghrelin levels are decreased in patients with obesity and T2DM ( 1 ) compared to eutrophic individuals, due to insulin-inhibitory effects on secretion ( 1 , 7 ). This evidence concerns the gene GHRL and obesity due to melanocortin 4 receptor deficiency.